WASHINGTON (dpa-AFX) - OncoGenex Pharmaceuticals Inc. (OGXI) said it has priced an underwritten public offering of 4.16 million shares at a purchase price of $12.00 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, would be about $46.8 million.
The company granted the underwriters a 30-day option to buy up to an additional 624,750 common shares to cover overallotments, if any. The offering may close on or about March 21, 2012.
Leerink Swann LLC and Stifel Nicolaus Weisel are acting as joint book-running managers and Lazard Capital Markets LLC and William Blair & Company, L.L.C. are acting as co-managers.
Copyright RTT News/dpa-AFX
© 2012 AFX News
